-transparent.png){kind=logo}
A series of 4-phenoxy-2-(1-piperazinyl)quinazolines was synthesized and examined for anticonvulsive and antihypoxic activities. Many of the compounds exhibited potent anticonvulsive activity comparable to that of carbamazepine or phenytoin. Among them, 4-phenoxy-2-(4-propyl-1-piperazinyl)quinazoline (5w) was selected as the most promising candidate antiepileptic drug with few side effects. It seemed that potent anticonvulsive activity was a prerequisite for potent antihypoxic activity.
Related Publications
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
May 2018,
Pakistan journal of pharmaceutical sciences,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
September 2012,
Yao xue xue bao = Acta pharmaceutica Sinica,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
January 1989,
Chemical & pharmaceutical bulletin,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
September 1994,
Arzneimittel-Forschung,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
July 1986,
Journal of medicinal chemistry,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
January 2005,
Journal of medicinal chemistry,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
September 1980,
Chemical & pharmaceutical bulletin,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
June 2010,
Bioorganic & medicinal chemistry letters,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
February 2007,
Journal of medicinal chemistry,
M Hori, and
R Iemura, and
H Hara, and
A Ozaki, and
T Sukamoto, and
H Ohtaka
January 2022,
BioMed research international,
